Cognitive impairment, including dementia, often goes undetected. Early detection of cognitive impairment is important because it enables patients and their families to access appropriate care supports and research opportunities. The majority of patients seeking evaluation of cognitive symptoms begin their diagnostic journey in primary care, but it is particularly challenging to detect cognitive impairment in primary care due to a number of factors. This study is piloting a digital cognitive screening tool and a cognitive assessment pathway in Penn Medicine primary care practices. Findings from this study will help us develop better care pathways for early detection of cognitive impairment.
Principal Investigator: Dr. Kyra O’Brien
Funding: Lilly USA, LLC; Davos Alzheimer’s Collaborative
Publications:
O’Brien KS, Harkins K, Peifer M, Kleid M, Coykendall C, Shea J, Karlawish J, Burke RE. Designing an intervention to improve cognitive evaluations in primary care. Implement Sci Commun. 2025 Jan 16;6(1):9. doi: 10.1186/s43058-025-00693-1. PMID: 39819971; PMCID: PMC11740457.
O’Brien K, Burke R, Karlawish J. A Roadmap for Modifying Clinician Behavior to Improve the Detection of Cognitive Impairment. J Gen Intern Med. 2023 Feb;38(2):508-512. doi: 10.1007/s11606-022-07824-7. PMID: 36163531; PMCID: PMC9905516.